FDA to present webinar on bioburden reduction with dry heat disinfection for single-use respirators
The U.S. Food and Drug Administration (FDA) announced it will host a webinar on the Enforcement Policy for Bioburden Reduction Systems Using Dry Heat to Support Single-User Reuse of Certain Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency on Tuesday, January 26, 12:00 p.m. to 1:00 p.m. ET.
This webinar is part of the series on Respirators and Other Personal Protective Equipment (PPE) for Healthcare Personnel Use during the COVID-19 Pandemic.
Representatives from the FDA, the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH), and Occupational Safety and Health Administration (OSHA) will be available to answer questions. Registration is not necessary.
PPE refers to protective clothing, helmets, gloves, face shields, goggles, surgical masks, respirators or other equipment designed to protect the wearer from injury or the spread of microorganisms.
The FDA has held webinars on device topics including PPE, protective barrier enclosures, sterilizers, disinfectant devices, and air purifiers used during the COVID-19 pandemic.
To ensure connection, dial in at 11:45 a.m.
U.S. Callers Dial:
888-455-1392
Conference number: PWXW1934848
Audience passcode: 7652118
International Callers Dial:
1-773-799-3847
Conference number: PWXW1934848
Audience passcode: 7652118
View the slide presentation during the webinar at https://www.mymeetings.com/nc/join.php?i=PWXW1934848&p=7652118&t=c.
